Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-23

Clinical Trial Update: Autonomic Phenotype Before and After Akt Inhibition

View source ↗

Summary

This clinical trial update notes that the study evaluating autonomic phenotype changes before and after Akt inhibition in melanoma patients has been withdrawn. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AKT inhibitor (AKT inhibitor)

Snippet

Sponsor: Vanderbilt University | Conditions: Diagnosis of Melanoma | Status: WITHDRAWN